Olema Pharmaceuticals, Inc. (OLMA)
7.48
+0.12
(+1.63%)
USD |
NASDAQ |
Nov 10, 10:01
Olema Pharmaceuticals Market Cap : 654.14M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 09, 2026 | 643.65M |
| November 06, 2026 | 641.02M |
| November 05, 2026 | 591.18M |
| November 04, 2026 | 659.39M |
| November 03, 2026 | 642.77M |
| November 02, 2026 | 618.29M |
| October 30, 2026 | 612.17M |
| October 29, 2026 | 641.02M |
| October 28, 2026 | 655.02M |
| October 27, 2026 | 615.66M |
| October 26, 2026 | 578.93M |
| October 23, 2026 | 560.57M |
| October 22, 2026 | 613.91M |
| October 21, 2026 | 616.54M |
| October 20, 2026 | 634.03M |
| October 19, 2026 | 621.79M |
| October 16, 2026 | 575.44M |
| October 15, 2026 | 600.80M |
| October 14, 2026 | 594.68M |
| October 13, 2026 | 613.91M |
| October 12, 2026 | 643.65M |
| October 09, 2026 | 683.88M |
| October 08, 2026 | 683.88M |
| October 07, 2026 | 694.37M |
| October 06, 2026 | 692.62M |
| Date | Value |
|---|---|
| October 05, 2026 | 721.48M |
| October 02, 2026 | 719.29M |
| October 01, 2026 | 723.23M |
| September 30, 2026 | 755.59M |
| September 29, 2026 | 746.84M |
| September 28, 2026 | 752.96M |
| September 25, 2026 | 765.21M |
| September 24, 2026 | 790.57M |
| September 23, 2026 | 772.20M |
| September 22, 2026 | 843.04M |
| September 21, 2026 | 842.16M |
| September 18, 2026 | 858.78M |
| September 17, 2026 | 865.78M |
| September 16, 2026 | 850.91M |
| September 15, 2026 | 855.28M |
| September 14, 2026 | 899.88M |
| September 11, 2026 | 893.76M |
| September 10, 2026 | 934.86M |
| September 09, 2026 | 906.00M |
| September 08, 2026 | 960.66M |
| September 04, 2026 | 940.11M |
| September 03, 2026 | 938.36M |
| September 02, 2026 | 947.11M |
| September 01, 2026 | 923.50M |
| August 31, 2026 | 912.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Puma Biotechnology, Inc. | 422.11M |
| SELLAS Life Sciences Group, Inc. | 1.773B |
| ACADIA Pharmaceuticals, Inc. | 3.007B |
| Alnylam Pharmaceuticals, Inc. | 21.16B |
| Anika Therapeutics, Inc. | 191.00M |
Market Cap Related Metrics
| PEG Ratio | -0.3477 |
| Price to Book Value | 1.519 |
| Price | 7.48 |
| Earnings Yield | -28.32% |
| PEGY Ratio | -0.3477 |